The absence of HIV mutations in cerebrospinal fluid and in peripheral blood mononuclear cells during a regimen containing Trizivir plus tenofovir

J Chemother. 2009 Aug;21(4):455-7. doi: 10.1179/joc.2009.21.4.455.
No abstract available

MeSH terms

  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Anti-HIV Agents / therapeutic use*
  • Cohort Studies
  • Drug Combinations
  • Drug Therapy, Combination
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV-1 / drug effects
  • HIV-1 / genetics*
  • Humans
  • Lamivudine / therapeutic use*
  • Leukocytes, Mononuclear / drug effects
  • Mutation / genetics*
  • Organophosphonates / therapeutic use*
  • Prospective Studies
  • Tenofovir
  • Viremia / blood*
  • Viremia / cerebrospinal fluid*
  • Viremia / drug therapy
  • Zidovudine / therapeutic use*

Substances

  • Anti-HIV Agents
  • Drug Combinations
  • Organophosphonates
  • abacavir, lamivudine, and zidovudine drug combination
  • Lamivudine
  • Zidovudine
  • Tenofovir
  • Adenine